menu
{ "item_title" : "Clinical Pharmacology in the Elderly", "item_author" : [" P. R. Heine", "Hans-Peter Breuel", "J. Kuhlmann "], "item_description" : "The appropriate and rational use of drugs by the elderly is a matter of growing medical and social concern. Persons aged 65 years and older constitute about 12%-15% of the population in the Western world, and the total number of the elderly will increase significantly in the coming years. This population accounts for 30% of all the prescription drugs used. Aging, specifically the transition from middle to old age, is a complex process. From the perspective of clinical pharmacology, these pathophysiological changes may reasonably be expected to alter responsiveness to drugs. The age-related differences in response to drugs can arise from alterations in pharmacokinetics or pharmacodynamics. This makes it mandatory that clinical pharma- cological studies be carried out in the elderly during extended phase I studies. The older the population likely to use the drug, the more important it is to include the very old. It is also important not to exclude ....: ''lecessarily patients with concomitant illnesses; it is only by observing, such patients that drug-disease interactions can be detected. Reports from surveillance systems have greatly increased our awareness of problems associated with drug therapy in old age.", "item_img_path" : "https://covers1.booksamillion.com/covers/bam/3/54/059/495/3540594957_b.jpg", "price_data" : { "retail_price" : "54.99", "online_price" : "54.99", "our_price" : "54.99", "club_price" : "54.99", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
Clinical Pharmacology in the Elderly|P. R. Heine

Clinical Pharmacology in the Elderly : Reference Ranges and Biological Variations After Repeated Measurements

local_shippingShip to Me
In Stock.
FREE Shipping for Club Members help

Overview

The appropriate and rational use of drugs by the elderly is a matter of growing medical and social concern. Persons aged 65 years and older constitute about 12%-15% of the population in the Western world, and the total number of the elderly will increase significantly in the coming years. This population accounts for 30% of all the prescription drugs used. Aging, specifically the transition from middle to old age, is a complex process. From the perspective of clinical pharmacology, these pathophysiological changes may reasonably be expected to alter responsiveness to drugs. The age-related differences in response to drugs can arise from alterations in pharmacokinetics or pharmacodynamics. This makes it mandatory that clinical pharma- cological studies be carried out in the elderly during extended phase I studies. The older the population likely to use the drug, the more important it is to include the very old. It is also important not to exclude ....: ''lecessarily patients with concomitant illnesses; it is only by observing, such patients that drug-disease interactions can be detected. Reports from surveillance systems have greatly increased our awareness of problems associated with drug therapy in old age.

This item is Non-Returnable

Details

  • ISBN-13: 9783540594956
  • ISBN-10: 3540594957
  • Publisher: Springer
  • Publish Date: December 1995
  • Dimensions: 9.21 x 6.14 x 0.41 inches
  • Shipping Weight: 0.61 pounds
  • Page Count: 182

Related Categories

You May Also Like...

    1

BAM Customer Reviews